Takeda Pharmaceutical Pre-Tax Income 2010-2024 | TAK

Takeda Pharmaceutical annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Takeda Pharmaceutical pre-tax income for the quarter ending June 30, 2024 was $0.874B, a 11.31% decline year-over-year.
  • Takeda Pharmaceutical pre-tax income for the twelve months ending June 30, 2024 was $0.253B, a 90.14% decline year-over-year.
  • Takeda Pharmaceutical annual pre-tax income for 2024 was $0.364B, a 86.88% decline from 2023.
  • Takeda Pharmaceutical annual pre-tax income for 2023 was $2.776B, a 3.07% increase from 2022.
  • Takeda Pharmaceutical annual pre-tax income for 2022 was $2.693B, a 21.78% decline from 2021.
Takeda Pharmaceutical Annual Pre-Tax Income
(Millions of US $)
2024 $364
2023 $2,776
2022 $2,693
2021 $3,443
2020 $-559
2019 $854
2018 $1,955
2017 $1,333
2016 $1,000
2015 $-1,323
2014 $1,589
2013 $1,569
2012 $3,206
2011 $4,477
2010 $4,471
2009 $-4,623
Takeda Pharmaceutical Quarterly Pre-Tax Income
(Millions of US $)
2024-06-30 $874
2024-03-31 $-376
2023-12-31 $417
2023-09-30 $-662
2023-06-30 $986
2023-03-31 $353
2022-12-31 $761
2022-09-30 $465
2022-06-30 $1,197
2022-03-31 $-531
2021-12-31 $635
2021-09-30 $559
2021-06-30 $2,029
2021-03-31 $1,221
2020-12-31 $1,054
2020-09-30 $-44
2020-06-30 $1,212
2020-03-31 $-536
2019-12-31 $229
2019-09-30 $-22
2019-06-30 $-229
2018-12-31 $424
2018-06-30 $864
2017-06-30 $1,784
2016-06-30 $1,392
2015-06-30 $400
2015-03-31 $3,673
2014-12-31 $1,542
2014-09-30 $4,076
2014-06-30 $588
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $507
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $947
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
2010-03-31 $3,728
2009-09-30 $2
2009-03-31 $3,594
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $43.846B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.775B 30.70
Merck (MKKGY) Germany $21.021B 22.94
Astellas Pharma (ALPMY) Japan $20.214B 18.62
Sandoz Group AG (SDZNY) Switzerland $19.826B 0.00
United Therapeutics (UTHR) United States $18.304B 18.01
Summit Therapeutics (SMMT) United States $15.789B 0.00
Neurocrine Biosciences (NBIX) United States $12.731B 33.71
Shionogi (SGIOY) Japan $12.473B 11.95
Catalent (CTLT) United States $10.784B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.649B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.633B 7.31
Orion OYJ (ORINY) Finland $6.848B 19.25
Corcept Therapeutics (CORT) United States $6.245B 47.30
Ionis Pharmaceuticals (IONS) United States $6.188B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.857B 0.00
PTC Therapeutics (PTCT) United States $3.406B 0.00
Dyne Therapeutics (DYN) United States $2.859B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 12.94
Arrowhead Pharmaceuticals (ARWR) United States $2.721B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.702B 16.17
Soleno Therapeutics (SLNO) United States $2.460B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.171B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.996B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.870B 0.00
Harrow (HROW) United States $1.863B 0.00
Ocular Therapeutix (OCUL) United States $1.731B 0.00
Xencor (XNCR) United States $1.653B 0.00
ARS Pharmaceuticals (SPRY) United States $1.652B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.611B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.535B 0.00
Evotec AG (EVO) Germany $1.464B 0.00
Indivior (INDV) United States $1.413B 5.76
Enliven Therapeutics (ELVN) United States $1.368B 0.00
Guardian Pharmacy Services (GRDN) United States $1.329B 0.00
Cassava Sciences (SAVA) United States $1.293B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.190B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 5.66
Bioventus (BVS) United States $0.957B 30.31
Relay Therapeutics (RLAY) United States $0.830B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.792B 0.00
USANA Health Sciences (USNA) United States $0.767B 14.22
Cronos Group (CRON) Canada $0.765B 0.00
Tourmaline Bio (TRML) United States $0.737B 0.00
Exscientia (EXAI) United Kingdom $0.658B 0.00
Korro Bio (KRRO) United States $0.655B 0.00
Savara (SVRA) United States $0.653B 0.00
ProKidney (PROK) United States $0.579B 0.00
Larimar Therapeutics (LRMR) United States $0.569B 0.00
Altimmune (ALT) United States $0.546B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 50.98
Siga Technologies (SIGA) United States $0.540B 6.31
Verve Therapeutics (VERV) United States $0.534B 0.00
OmniAb (OABI) United States $0.534B 0.00
Silence Therapeutics (SLN) United Kingdom $0.524B 0.00
Xeris Biopharma Holdings (XERS) United States $0.517B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
KalVista Pharmaceuticals (KALV) United States $0.493B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.437B 0.00
Organogenesis (ORGO) United States $0.435B 0.00
4D Molecular Therapeutics (FDMT) United States $0.422B 0.00
Akebia Therapeutics (AKBA) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.388B 157.64
Sage Therapeutics (SAGE) United States $0.386B 0.00
Aldeyra Therapeutics (ALDX) United States $0.328B 0.00
Lyell Immunopharma (LYEL) United States $0.312B 0.00
Avita Medical (RCEL) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 16.37
Acrivon Therapeutics (ACRV) United States $0.265B 0.00
Heron Therapeutics (HRTX) United States $0.265B 0.00
Lexeo Therapeutics (LXEO) United States $0.264B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Nektar Therapeutics (NKTR) United States $0.258B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
Nanobiotix S.A (NBTX) France $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.189B 0.00
Galectin Therapeutics (GALT) United States $0.187B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Cardiol Therapeutics (CRDL) Canada $0.159B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Context Therapeutics (CNTX) United States $0.146B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Century Therapeutics (IPSC) United States $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Fractyl Health (GUTS) United States $0.118B 0.00
OptiNose (OPTN) United States $0.118B 0.00
Journey Medical (DERM) United States $0.117B 0.00
Karyopharm Therapeutics (KPTI) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Regulus Therapeutics (RGLS) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.094B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.087B 0.00
CASI Pharmaceuticals (CASI) China $0.085B 0.00
Assertio Holdings (ASRT) United States $0.081B 14.17
ESSA Pharma (EPIX) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Metagenomi (MGX) United States $0.076B 0.00
Citius Pharmaceuticals (CTXR) United States $0.074B 0.00
AlloVir (ALVR) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Prelude Therapeutics (PRLD) United States $0.065B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
BGM Group (BGM) China $0.053B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
VYNE Therapeutics (VYNE) United States $0.047B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
DURECT (DRRX) United States $0.041B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
BioLineRx (BLRX) Israel $0.036B 0.00
Surrozen (SRZN) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
BioVie (BIVI) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Inhibikase Therapeutics (IKT) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.020B 0.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Ainos (AIMD) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.71